A phase 1 dose-escalation trial of intravesical CG0070 for superficial transitional cell carcinoma of the bladder after bacillus calmette-guerin failure

Trial Profile

A phase 1 dose-escalation trial of intravesical CG0070 for superficial transitional cell carcinoma of the bladder after bacillus calmette-guerin failure

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 22 May 2008

At a glance

  • Drugs CG 0070 (Primary)
  • Indications Bladder cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 22 May 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.
    • 22 May 2008 Interim results have been presented at the 103rd Annual Meeting of the American Urological Association, held in Orlando, Florida USA.
    • 17 Jan 2008 The expected completion date for this trial is now 1 Sep 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top